-
公开(公告)号:US20200151516A1
公开(公告)日:2020-05-14
申请号:US16680458
申请日:2019-11-11
申请人: CurieAI, Inc.
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: feeding a first set of input features to the AI model; obtaining a first set of raw output predictions from the model; determining a first set of impact scores for the input features fed into the model; training a neural network with the first set of impact scores as input to the network and pre-determined sentences describing the model's behavior as output; feeding a second set of input features to the AI model; obtaining a second set of raw output predictions from the model; determining a second set of impact scores based on the second set of output predictions; feeding the second set of impact scores to the neural network; and generating a sentence describing the AI model's behavior on the second set of input features.
-
公开(公告)号:US20200152330A1
公开(公告)日:2020-05-14
申请号:US16680453
申请日:2019-11-11
申请人: CurieAI, Inc.
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: generating, using one or more processors, profiles for a plurality of users, each profile including information collected from monitoring users over time; categorizing, using the one or more processors, a set of users into one or more predetermined categories based on the generated profiles; and recommending, using the one or more processors, a set of actions for each category of users.
-
公开(公告)号:US10977522B2
公开(公告)日:2021-04-13
申请号:US16680455
申请日:2019-11-11
申请人: CurieAI, Inc.
IPC分类号: G06K9/62 , G06N3/04 , G16H10/60 , G16H80/00 , G16H40/67 , G16H50/20 , A61B5/08 , A61B5/00 , G06N3/08 , G10L15/02 , G10L15/16 , G10L15/22 , G10L25/66 , G16H50/70 , G16H20/10 , G06F17/16 , G06F17/18 , G16H70/60 , G16H70/40 , A61B5/0205 , A61B5/11 , A61B5/1455 , G06N20/10 , G06K9/72 , G10L15/18 , A61B5/024
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: obtaining, using one or more processors of a device, a speech sample from a user uttering a first sentence; processing the speech sample through a neural network to predict a first set of one or more disease-related symptoms of the user; and generating, using the one or more processors, a second sentence to predict a second set of one or more disease-related symptoms or confirm the first set of disease-related symptoms.
-
公开(公告)号:US11055575B2
公开(公告)日:2021-07-06
申请号:US16680429
申请日:2019-11-11
申请人: CurieAI, Inc.
IPC分类号: A61B5/00 , G06K9/62 , G06N3/04 , G16H10/60 , G16H80/00 , G16H40/67 , G16H50/20 , A61B5/08 , G06N3/08 , G10L15/02 , G10L15/16 , G10L15/22 , G10L25/66 , G16H50/70 , G16H20/10 , G06F17/16 , G06F17/18 , G16H70/60 , G16H70/40 , A61B5/0205 , A61B5/11 , A61B5/1455 , G06N20/10 , G06K9/72 , G10L15/18 , A61B5/024
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: capturing, using one or more sensors of a device, signals including information about a user's symptoms; using one or more processors of the device to: collect other data correlative of symptoms experienced by the user; and implement pre-trained data driven methods to: determine one or more symptoms of the user; determine a disease or disease state of the user based on the determined one or more symptoms; determine a medication effectiveness in suppressing at least one determined symptom or improving the determined disease state of the user; and present, using an output device, one or more evidence for at least one of the determined symptoms, the disease, disease state, or an indication of the medication effectiveness for the user.
-
公开(公告)号:US10706329B2
公开(公告)日:2020-07-07
申请号:US16680458
申请日:2019-11-11
申请人: CurieAI, Inc.
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: feeding a first set of input features to the AI model; obtaining a first set of raw output predictions from the model; determining a first set of impact scores for the input features fed into the model; training a neural network with the first set of impact scores as input to the network and pre-determined sentences describing the model's behavior as output; feeding a second set of input features to the AI model; obtaining a second set of raw output predictions from the model; determining a second set of impact scores based on the second set of output predictions; feeding the second set of impact scores to the neural network; and generating a sentence describing the AI model's behavior on the second set of input features.
-
公开(公告)号:US20200152226A1
公开(公告)日:2020-05-14
申请号:US16680455
申请日:2019-11-11
申请人: CurieAI, Inc.
IPC分类号: G10L25/66 , G10L15/02 , G10L15/22 , G10L15/16 , G06N3/04 , G06N3/08 , G16H50/20 , G16H40/67 , A61B5/00 , A61B5/08
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: obtaining, using one or more processors of a device, a speech sample from a user uttering a first sentence; processing the speech sample through a neural network to predict a first set of one or more disease-related symptoms of the user; and generating, using the one or more processors, a second sentence to predict a second set of one or more disease-related symptoms or confirm the first set of disease-related symptoms.
-
公开(公告)号:US20200146623A1
公开(公告)日:2020-05-14
申请号:US16680429
申请日:2019-11-11
申请人: CurieAI, Inc.
IPC分类号: A61B5/00 , A61B5/0205 , A61B5/1455 , A61B5/11 , G16H20/10 , G16H70/40 , G16H70/60 , G16H50/20
摘要: Embodiments are disclosed for health assessment and diagnosis implemented in an artificial intelligence (AI) system. In an embodiment, a method comprises: capturing, using one or more sensors of a device, signals including information about a user's symptoms; using one or more processors of the device to: collect other data correlative of symptoms experienced by the user; and implement pre-trained data driven methods to: determine one or more symptoms of the user; determine a disease or disease state of the user based on the determined one or more symptoms; determine a medication effectiveness in suppressing at least one determined symptom or improving the determined disease state of the user; and present, using an output device, one or more evidence for at least one of the determined symptoms, the disease, disease state, or an indication of the medication effectiveness for the user.
-
-
-
-
-
-